Niigata University of Health and Welfare · Faculty of Medical Technology · 教授

Research keywordsペプチド・水酸化酵素・癌生物学 ペプチド創薬・腫瘍生物学、実験病理学、創薬化学・Cancer and Molecular biology・Protein and Peptite Engineering・Biochemistry

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• 1. Mitsui A, Iioka H, Ling Y, Okuda S, Kurose A, Schopperie M, Kondo T, Sakaguchi M, Saito K, Kondo E. Pathological and biological significance of the specific glycan, TRA-1-60, on aggressive gastric adenocarcinoma. Lab Invest. (2024) doi: 10.1016/j.labinv.2024.1020732024
• 1. Mitsui A, Iioka H, Ling Y, Okuda S, Kurose A, Schopperie M, Kondo T, Sakaguchi M, Saito K, Kondo E. Pathological and biological significance of the specific glycan, TRA-1-60, on aggressive gastric adenocarcinoma. Lab Invest. (2024) doi: 10.1016/j.labinv.2024.1020732024
• 2. Fujisaki T, Saito K, Kikuchi T, Kondo E The prolyl hydroxylase OGFOD1 promotes cancer cell proliferation by regulating the expression of cell cycle regulators. FEBS Lett. (2022) doi: 10.1002/1873-3468.14547.2022
• 2. Fujisaki T, Saito K, Kikuchi T, Kondo E The prolyl hydroxylase OGFOD1 promotes cancer cell proliferation by regulating the expression of cell cycle regulators. FEBS Lett. (2022) doi: 10.1002/1873-3468.14547.2022

• 難治性リンパ腫の免疫回避機構の解明と新しい治療法の開発
• 難治性リンパ腫の免疫回避機構の解明と新しい治療法の開発
• ミトコンドリア機能型p14ペプチドによる新たな基盤情報の獲得と制がん技術の開発
• ホーミングペプチドを基盤にした新規膵癌バイオマーカー及び膵癌標的化抗体医薬の開発

• Official profile